Article
Risk assessment of cancer patients based on HLA-I alleles, neobinders and expression of cytokines
2022-10-18
Abstract excerpt
Advancements in cancer immunotherapy have shown significant outcomes in treating various types of cancers. In order to design effective immunotherapy, it is important to understand immune response of a patient based on its genomic profile. We compute prognostic biomarkers from 8346 cancer patients for twenty types of cancer. These prognostic biomarkers has been computed based on i) presence of 352 human leucocyte...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8d4097ff-c274-5de0-8d5d-05866ccfd825
- DOI
- 10.1101/2022.10.15.512339
